Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
30 June 2017
E-004391-17
Question for written answer
to the Commission
Rule 130
Neena Gill (S&D)

 Subject:  Funding for brain cancer research, treatment and prevention
 Answer(s) 

There are an estimated 30 715 cases of brain cancer in Europe each year. Given that the survival rate is around 10%, it is clear that very little is understood about how to treat the disease.

Could the Commission provide a breakdown of data on the total amount of funding for cancer research, treatment and prevention in general, and detail the exact amount of funding spent on brain cancer in particular?

Will the Commission address the low level of funding earmarked for brain cancer in the forthcoming budget and Multiannual Financial Framework?

Last updated: 13 July 2017Legal notice